Case 1 |
Case 2 |
Case 3 |
Case 4 |
Case 5 |
Case 6 |
|
WBC (/μl) |
6300 |
4700 |
5700 |
4200 |
6700 |
7200 |
Hb (g/dl) |
10.7 |
8.4 |
7.5 |
7.7 |
12.9 |
11 |
Ht (%) |
32.5 |
24.5 |
22.2 |
22.9 |
37.8 |
34.5 |
Ret. (%) |
28 |
63 |
24 |
68 |
33 |
12 |
Plt (×104/μl) |
17.7 |
22.9 |
26.5 |
21.2 |
9.6 |
16.6 |
NCC (×104/μl) |
1.85 |
11.5 |
17 |
16 |
Dry tap |
3.76 |
Mgk (/μl) |
18.75 |
56.25 |
81.25 |
12.5 |
Dry tap |
0 |
M/E |
3 |
1.3 |
2.8 |
4 |
Dry tap |
1.8 |
Chromosome |
46,XX,del(9)(q?) |
45,X-Y |
46,XX |
46,XX |
Not done |
46,XX |
Hb in stool |
( - ) |
( - ) |
( - ) |
( - ) |
Not done |
|
Ferritin (ng/ml) |
266 |
629 |
2185 |
451 |
79 |
81 |
Albumin
(g/dl) |
3.7 |
3.4 |
4.2 |
3.7 |
4.5 |
4.1 |
Cholesterol
(mg/dl) |
239 |
137 |
137 |
166 |
214 |
226 |
LDH (U/L) |
1792 |
272 |
469 |
1100 |
237 |
250 |
Haptoglobin |
<10 |
<10 |
73 |
<10 |
48 |
Not done |
ParvovirusB19・IgM antibody |
( - ) |
( - ) |
( - ) |
( - ) |
( - ) |
( - ) |
ParvovirusB19・IgG antibody |
3.46 |
5.97 |
1.63 |
7.36 |
6.09 |
7.24 |
Anti-nuclear antibody(ANA) |
( + ) |
( - ) |
( - ) |
( - ) |
( + ) |
( + ) |
Immunological abnormality |
Ind・Coombs(+)ANA(+) |
S-IL2R(684) |
D・Coombs(±)S-IL2R(546) |
S-IL2R(423) |
S-IL2R(1330)・ANA(+) |
S-IL2R(734)・ANA(+) |
Abnormal immunoglobulin |
IgG(625) |
IgG(850)IgA(20) |
IgM(30) |
IgG(652) |
Not done |
IgG(591)IgA(99) |
Others before hospitalization |
FT3(0.97)FT4(0.66) |
Pollenosis |
Skin rash with eosinophilia |
β2MG(6.4) |
Skin rash by antibiotics |
Asthma |
S- IL2R: Soluble IL-2 Receptor, WBC:
White Blood Cell, Hb: Hemoglobin, Ht: Hematocrit, Ret: Reticulocyte, Plt: Platelet, NCC: Nuclear Cell Count, Mgk: Megakaryocyte, M/E:
Myelocyte-Erythrocyte Ratio |
||||||
FT3, free T3; FT4, free T4; β2MG,
β2microglobulin) |
|
|
|
|
|
|
(Within normal limit: IgG, 870mg/dl~; IgA, 110mg/dl~; IgM, 35mg/dl~; albumin, 3.9g/dl~; cholesterol, 150mg/dl~; LDH, ~229U/L; ferritin, ~200ng/ml; S-IL2R, ~519U/ml; FT3, 2.30pg/ml; |
||||||
FT4, ~; 0.80ng/ml~; β2MG, ~2.0mg/L) |
|
|
|
|
|
|
Table 1:
Picture of the cases